This research develops an affordable, rapid genetic testing system to personalize antidepressant treatment. By detecting DNA mutations that affect drug metabolism, the technology helps doctors prescribe the right medication for each patient. The goal is to reduce ineffective treatments and improve mental health care—especially for veterans struggling with PTSD and depression.

This research examines whether anhedonia—a core symptom of depression marked by reduced pleasure and motivation—is linked to impairments in working and episodic memory. While memory performance did not differ across anhedonia levels, the findings highlight the need for further study to develop targeted, memory-based interventions.